How Itron’s Expanded Cellular and Legacy Metering Support At Itron (ITRI) Has Changed Its Investment Story

• Itron recently expanded its UtilityIQ Application Suite to support new Cellular 500G and 500W modules in the US, while Tantalus Systems extended its license agreement to maintain full compatibility with Itron’s legacy ERT metering technologies across the TRUConnect AMI platform.
• Together, these moves strengthen Itron’s role at the center of grid modernization by helping utilities bridge legacy metering assets with flexible, multi-transport AMI deployments.
• We’ll now examine how Itron’s enhanced cellular modules and extended ERT compatibility influence its investment narrative and long-term grid modernization outlook.

Uncover the next big thing with 33 elite penny stocks that balance risk and reward.

Itron Investment Narrative Recap

To own Itron, you need to believe utilities will keep prioritizing grid modernization and that Itron’s interoperable platforms remain central to those upgrades. The new cellular modules and extended ERT license help address deployment friction and protect installed assets, but they do not fundamentally change the near term risk that regulatory delays and stretched utility budgets could still slow large AMI rollouts and create lumpier revenue.

Among recent announcements, the expansion of Itron’s UtilityIQ Application Suite to support Cellular 500G and 500W modules looks most directly tied to the grid modernization catalyst. By enabling multi transport, multi vendor AMI deployments that integrate both mesh and public cellular networks under a single headend, this update supports a more modular, capital efficient path for utilities to progress projects even when large, all at once deployments face regulatory or funding hurdles.

Yet, while these technology moves are helpful, investors should still be aware that prolonged regulatory approval cycles could...

Read the full narrative on Itron (it's free!)

Itron's narrative projects $2.8 billion revenue and $388.8 million earnings by 2028.

Uncover how Itron's forecasts yield a $136.80 fair value, a 49% upside to its current price.

Exploring Other Perspectives

Four fair value estimates from the Simply Wall St Community span roughly US$72.87 to US$167.02 per share, showing how far apart individual views can be. You should weigh that spread against the risk that utility capital constraints and elongated regulatory approvals may keep near term project timing uneven, and consider how different scenarios could affect Itron’s ability to translate its technology position into sustained financial performance.

Explore 4 other fair value estimates on Itron - why the stock might be worth as much as 82% more than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Itron research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Itron research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Itron's overall financial health at a glance.

Ready For A Different Approach?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Invest in the nuclear renaissance through our list of 86 elite nuclear energy infrastructure plays powering the global AI revolution.
• Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• This technology could replace computers: discover 22 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com